Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Apr;126(7):1534-6.
doi: 10.1038/sj.bjp.0702468.

Functional evidence of alpha1D-adrenoceptors in the vasculature of young and adult spontaneously hypertensive rats

R Villalobos-Molina  1 , J J López-Guerrero, M Ibarra
Affiliations

Functional evidence of alpha1D-adrenoceptors in the vasculature of young and adult spontaneously hypertensive rats

R Villalobos-Molina et al. Br J Pharmacol. 1999 Apr.

Abstract

The role of alpha1D-adrenoceptors in the vasculature of spontaneously hypertensive (SHR) and normotensive Wistar Kyoto rats (WKY), of different ages was assessed in pithed rats by the use of the selective alpha1D-adrenoceptor antagonist BMY 7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]-ethyl]-8-azaspiro [4.5]decane-7,9-dione dihydrochloride). BMY 7378 displaced the pressor effect of phenylephrine in young pre-hypertensive pithed SHR rats, but produced no effect in young WKY rats (dose ratio of 3.4 and 1.6, respectively), while in adult rats BMY 7378 produced a greater shift in the phenylephrine response curve than in younger animals (dose ratio of 3.2 and 6.2 in WKY and SHR, respectively). The presence of alpha1D-adrenoceptors in the vasculature of pre-hypertensive rats, suggests its role in the pathogenesis/maintenance of increased blood pressure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Antagonist action of BMY 7378 in the pressor response to phenylephrine in WKY and SHR rats of different age. Pithed rats of 1 and 6 months of age were subjected to increasing i.v. doses of phenylephrine. (A) WKY, 1 month; (B) WKY, 6 months; (C) SHR, 1 month; (D) SHR, 6 months. Points represent the mean±s.e.mean of 3–7 rats.
See this image and copyright information in PMC

References

    1. DENG X.F., CHEMTOB S., VARMA D.R. Characterization of α1-adrenoceptor subtype in rat myocardium, aorta and other tissues. Br. J. Pharmacol. 1996;119:269–276. - PMC - PubMed
    1. HIEBLE J.P., BYLUND D.B., CLARK D.E., EIKENBURG D.C., LANGER S.Z., LEFKOWITZ R.J., MINNEMAN K.P., RUFFOLO R.R., JR International Union of Pharmacology X. Recommendation for nomenclature of α1-adrenoceptors: consensus update. Pharmacol. Rev. 1995;47:267–270. - PubMed
    1. IBARRA M., LÓPEZ-GUERRERO J.J., VILLALOBOS-MOLINA R. Further evidence for the predominance of α1D-adrenoceptors in arteries of normotensive and spontaneously hypertensive rats. Pharmacol. Rev. Comm. 1998;10:135–142.
    1. IBARRA M., TERRÓN J.A., LÓPEZ-GUERRERO J.J., VILLALOBOS-MOLINA R. Evidence for an age-dependent functional expression of α1D-adrenoceptors in the rat vasculature. Eur. J. Pharmacol. 1997;322:221–224. - PubMed
    1. PIASCIK M.T., HROMETZ S.L., EDELMANN S.E., GUARINO R.D., HADLEY R.W., BROWN R.D. Immunocytochemical localization of the alpha-1B adrenergic receptor and the contribution of this and other subtypes to vascular smooth muscle contraction: analysis with selective ligands and antisense oligonucleotides. J. Pharmacol. Expt. Ther. 1997;283:854–868. - PubMed

Publication types